Morbidity and mortality in adult polymyositis and dermatomyositis.
about
Elevated risk of venous thromboembolic events in patients with inflammatory myopathiesCardiac involvement in adult and juvenile idiopathic inflammatory myopathiesTherapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease.Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.An overview of polymyositis and dermatomyositis.Lupus Myocarditis: A Case-Control Study from China.Atherosclerotic cardiovascular disease and dermatomyositis: an analysis of the Nationwide Inpatient Sample surveyLatest advances in connective tissue disorders.Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study.Sex differential association of dermatomyositis with Sjögren syndrome.Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.IL-6, IL-8, and IL-10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositisClinical heterogeneity and outcomes of antisynthetase syndrome.Predictors of Hospitalization, Length of Stay, and Cost of Care Among Adults With Dermatomyositis in the United States.Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain.Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study.Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study.Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD).Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery.[New aspects on the pathogenesis of myositis].[Early symptoms of dermatomyositis and antisynthetase syndrome].Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study.The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.Quality of life correlates with muscle strength in patients with dermato- or polymyositis.Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis.Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India.Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.[Inflammatory myopathies].Case Report: Acute amyopathic dermatomyositis presenting with isolated facial edema.Current Classification and Management of Inflammatory Myopathies.
P2860
Q26746904-25947825-CB32-4803-8198-8B38C5A3A9F3Q28079786-B82C323D-9D0C-499F-B38B-F6EDD824885FQ30300509-DDFAB37E-D185-41D2-B560-A5C361985B9DQ33926524-46F098EF-8F7C-4976-A72D-C461BBBC6FEEQ34349952-B2065104-4AFE-4450-BCCD-341E0ED4DFF8Q34667765-F846005A-7B99-4C09-893C-66C983AD97A6Q36531819-C65DD422-710E-4E65-B175-8A489E9CE584Q36903269-FAA0E82C-6CF1-48C4-AA35-1A1415D5EB06Q37058776-E72EDCA9-3ACE-4737-9083-E3174AC379FBQ37102484-DE915CD1-DA4B-40C2-AEAC-7D4069A8BE93Q37621925-9CA42989-2CC7-4BEA-8202-736FA4CD041CQ37690885-17B9495F-F445-4D7C-A689-B4F0458E1B2EQ37706152-9970C4DE-FF1A-4A67-85E1-9C5DF7C7D394Q38116464-6B60995E-4A8A-4EBA-9B1B-3651D5F9233DQ38757183-DAB8ADED-402B-4126-8E5C-42B0963821C2Q39114608-401C2706-B1C6-4A95-9CB7-5D0A01D22FA7Q40069189-DFF0ABA5-C026-4DB1-87FA-560882AE08D8Q40263745-F184C1C4-1AAF-4550-9D24-B6EDB3D09B13Q40474641-967DB533-92DE-4C86-9B6C-2163B77C3AFAQ40479785-2CDEE016-CBFC-4FF8-A923-47288BB7D3B4Q40534854-EE3DBA87-FA68-4B93-AB0D-7A032FE3E0C5Q41538311-61FB185E-0741-4A01-B954-662FFFE64CD8Q42010588-25FA4890-51EE-4F04-97F2-7B647D7568D2Q43978656-79E2679E-A9D7-41F4-991F-C7C96D604294Q44920626-9EA4F653-313F-4CFC-AD30-6A83D8B622C9Q47238762-82B7EE56-7E57-4840-8DC0-D86176C9EFCDQ47425244-83A6584C-058A-4901-8837-064791E19550Q47659489-0003BE61-665F-4DC6-A892-89FF133B8565Q47702601-3444D45D-CEDF-404A-B640-A0694AC7F876Q49296473-50CCA017-0223-448B-8D32-E624DE0FBAF2Q50654020-AB06DD72-22A6-438F-8F70-B567CE7364FDQ51280183-750A395E-8474-44C0-A3DD-E5F2C73FD08BQ52797027-A6FB08A9-773B-460D-95D3-E597699C9FC0Q54225589-75A5211C-8EE1-4F29-82E3-C0605A877B27Q54977148-96EB4BD7-3681-4E9E-BB8C-257185A2585D
P2860
Morbidity and mortality in adult polymyositis and dermatomyositis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Morbidity and mortality in adult polymyositis and dermatomyositis.
@ast
Morbidity and mortality in adult polymyositis and dermatomyositis.
@en
Morbidity and mortality in adult polymyositis and dermatomyositis.
@nl
type
label
Morbidity and mortality in adult polymyositis and dermatomyositis.
@ast
Morbidity and mortality in adult polymyositis and dermatomyositis.
@en
Morbidity and mortality in adult polymyositis and dermatomyositis.
@nl
prefLabel
Morbidity and mortality in adult polymyositis and dermatomyositis.
@ast
Morbidity and mortality in adult polymyositis and dermatomyositis.
@en
Morbidity and mortality in adult polymyositis and dermatomyositis.
@nl
P2860
P1476
Morbidity and mortality in adult polymyositis and dermatomyositis.
@en
P2093
Isabelle Marie
P2860
P2888
P304
P356
10.1007/S11926-012-0249-3
P577
2012-06-01T00:00:00Z
P6179
1016486166